Applied Neurosolutions
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(847) 573-8000Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Applied Neurosolutions
Applied NeuroSolutions, Inc. (OTC BB: APNS) is developing products to diagnose and treat Alzheimer's disease based on a novel hypothesis of AD pathology. In partnership with Dr. Peter Davies and a scientific team at Albert Einstein College of Medicine, Applied NeuroSolutions has developed a cerebrospinal fluid (CSF) test to detect Alzheimer's disease at a very early stage with 85%-95% accuracy in more than 3,000 patient samples. There are approximately 2 million new patients annually worldwide who are candidates for an AD CSF diagnostic test, according to Datamonitor. The company is also developing a blood serum-based screening test, as well as a new class of therapeutics to treat AD. Alzheimer's disease currently afflicts over 4 million Americans, and the market for AD therapy is expected to grow to 21 million patients by 2010 in the seven major pharmaceutical markets (USA, France, Germany, Italy, Spain, U.K. and Japan) according to BioPortfolio, Ltd. There are currently no FDAapproveRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Applied Neurosolutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Applied Neurosolutions has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Applied Neurosolutions is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Applied Neurosolutions
Check if Applied Neurosolutions has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Applied Neurosolutions launches new products
Click to see if Applied Neurosolutions had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Applied Neurosolutions, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Applied Neurosolutions recently announced quarterly report
Recommended Actions
Find VP level buyers at Applied Neurosolutions
Find more new buyers
Compare Similar Companies to Applied Neurosolutions
Compare insights from companies similar to Applied Neurosolutions, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Applied Neurosolutions
<$5M
11-50
Private
-
1991
N/A
Company Profile Activity
Activity Insights
Applied Neurosolutions is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Applied Neurosolutions is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Applied Neurosolutions.
Applied Neurosolutions Tech Stack
A closer look at the technologies used by Applied Neurosolutions
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Applied Neurosolutions
Sign Up For FreeTo access detailed company insights
Applied NeuroSolutions, Inc. (OTC BB: APNS) is developing products to diagnose and treat Alzheimer's disease based on a novel hypothesis of AD pathology. In partnership with Dr. Peter Davies and a scientific team at Albert Einstein College of Medicine, Applied NeuroSolutions has developed a cerebrospinal fluid (CSF) test to detect Alzheimer's disea... Read More
